The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19
- PMID: 34054572
- PMCID: PMC8155253
- DOI: 10.3389/fphys.2021.653985
The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19
Abstract
The renin angiotensin system and the cholinergic anti-inflammatory pathway have been recently shown to modulate lung inflammation in patients with COVID-19. We will show how studies performed on this disease are starting to provide evidence that these two anti-inflammatory systems may functionally interact with each other, a mechanism that could have a more general physiological relevance than only COVID-19 infection.
Keywords: angiotensin-converting enzyme 2; inflammation; lung; nicotinic acetylcholine receptors; severe acute respiratory syndrome coronavirus 2.
Copyright © 2021 Di Maro, Cataldi, Santillo, Chiurazzi, Damiano, De Conno, Colantuoni and Guida.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Alexandris N., Lagoumintzis G., Chasapis C. T., Leonidas D. D., Papadopoulos G. E., Tzartos S. J., et al. (2020). Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol. Rep. 8 73–83. 10.1016/j.toxrep.2020.12.013 - DOI - PMC - PubMed
-
- Alqahtani J. S., Oyelade T., Aldhahir A. M., Alghamdi S. M., Almehmadi M., Alqahtani A. S., et al. (2020). Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One 15:e0233147. 10.1371/journal.pone.0233147 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
